1. Home
  2. CGO vs ANIX Comparison

CGO vs ANIX Comparison

Compare CGO & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGO
  • ANIX
  • Stock Information
  • Founded
  • CGO 2004
  • ANIX 1982
  • Country
  • CGO United States
  • ANIX United States
  • Employees
  • CGO N/A
  • ANIX N/A
  • Industry
  • CGO Investment Managers
  • ANIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CGO Finance
  • ANIX Health Care
  • Exchange
  • CGO Nasdaq
  • ANIX Nasdaq
  • Market Cap
  • CGO 117.5M
  • ANIX 101.4M
  • IPO Year
  • CGO N/A
  • ANIX 1987
  • Fundamental
  • Price
  • CGO $11.73
  • ANIX $3.08
  • Analyst Decision
  • CGO
  • ANIX Strong Buy
  • Analyst Count
  • CGO 0
  • ANIX 2
  • Target Price
  • CGO N/A
  • ANIX $8.50
  • AVG Volume (30 Days)
  • CGO 34.7K
  • ANIX 128.3K
  • Earning Date
  • CGO 01-01-0001
  • ANIX 01-14-2025
  • Dividend Yield
  • CGO 9.25%
  • ANIX N/A
  • EPS Growth
  • CGO N/A
  • ANIX N/A
  • EPS
  • CGO N/A
  • ANIX N/A
  • Revenue
  • CGO N/A
  • ANIX N/A
  • Revenue This Year
  • CGO N/A
  • ANIX N/A
  • Revenue Next Year
  • CGO N/A
  • ANIX N/A
  • P/E Ratio
  • CGO N/A
  • ANIX N/A
  • Revenue Growth
  • CGO N/A
  • ANIX N/A
  • 52 Week Low
  • CGO $7.90
  • ANIX $2.15
  • 52 Week High
  • CGO $10.93
  • ANIX $5.13
  • Technical
  • Relative Strength Index (RSI)
  • CGO 44.43
  • ANIX 42.34
  • Support Level
  • CGO $11.49
  • ANIX $3.07
  • Resistance Level
  • CGO $11.84
  • ANIX $4.20
  • Average True Range (ATR)
  • CGO 0.29
  • ANIX 0.30
  • MACD
  • CGO -0.02
  • ANIX -0.06
  • Stochastic Oscillator
  • CGO 36.49
  • ANIX 2.61

About CGO Calamos Global Total Return Fund

Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in global equities, convertible securities, and high-yield corporate bonds.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Share on Social Networks: